Search

Your search keyword '"Paul, Dirk S"' showing total 328 results

Search Constraints

Start Over You searched for: Author "Paul, Dirk S" Remove constraint Author: "Paul, Dirk S"
328 results on '"Paul, Dirk S"'

Search Results

1. Damaging mutations in liver X receptor-α are hepatotoxic and implicate cholesterol sensing in liver health

2. Protein-truncating variants in BSN are associated with severe adult-onset obesity, type 2 diabetes and fatty liver disease

3. Natural History and Clinicopathological Associations of TRPC6-Associated Podocytopathy

4. Rare variant associations with plasma protein levels in the UK Biobank

5. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets

6. Misexpression of inactive genes in whole blood is associated with nearby rare structural variants

7. Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease

8. Elucidating mechanisms of genetic cross-disease associations at the PROCR vascular disease locus

9. The common VTE-protective G haplotype of F5 increases factor V-short, TFPI function, and risk of bleeding

10. An atlas of genetic scores to predict multi-omic traits

11. FinnGen provides genetic insights from a well-phenotyped isolated population

13. Author Correction: Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets

15. Publisher Correction: Elucidating mechanisms of genetic cross-disease associations at the PROCR vascular disease locus

16. Donor whole blood DNA methylation is not a strong predictor of acute graft versus host disease in unrelated donor allogeneic haematopoietic cell transplantation

17. Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities

18. Author Correction: FinnGen provides genetic insights from a well-phenotyped isolated population

19. Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms

20. Quantitative comparison of DNA methylation assays for biomarker development and clinical applications

21. Genome-wide analysis of blood lipid metabolites in over 5000 South Asians reveals biological insights at cardiometabolic disease loci

22. Genetic determinants of blood gene expression and splicing and their contribution to molecular phenotypes and health outcomes

23. Assessing the role of rare pathogenic variants in heart failure progression by exome sequencing in 8,089 patients

24. Strong protective effect of theAPOL1p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease

25. Protein-truncating variants inBSNare associated with severe adult-onset obesity, type 2 diabetes and fatty liver disease

26. Protein-truncating variants in BSNare associated with severe adult-onset obesity, type 2 diabetes and fatty liver disease

27. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated 22 disease risk and therapeutic targets

28. FinnGen provides genetic insights from a well-phenotyped isolated population

29. Genomic atlas of the human plasma proteome

30. Genomic discovery and functional validation of MRP1 as a novel fetal hemoglobin modulator and potential therapeutic target in sickle cell disease

31. Genetic regulation of fetal hemoglobin across global populations

33. Correction to: Functional variation in allelic methylomes underscores a strong genetic contribution and reveals novel epigenetic alterations in the human epigenome

34. Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes

35. Inhibition of MRP1 Induces Fetal Hemoglobin through NRF2 Activation to Protect Human Erythroid Cells from Sickling

39. Integrated analyses of growth differentiation factor-15 concentration and cardiometabolic diseases in humans

40. Author response: Integrated analyses of growth differentiation factor-15 concentration and cardiometabolic diseases in humans

41. Pharmacogenomic study of heart failure and candesartan response from the CHARM programme

43. An atlas of genetic scores to predict multi-omic traits

44. Genetically personalised organ-specific metabolic models in health and disease

45. Donor whole blood DNA methylation is not a strong predictor of acute graft versus host disease in unrelated donor allogeneic haematopoietic cell transplantation

46. FinnGen: Unique genetic insights from combining isolated population and national health register data

47. Functional variation in allelic methylomes underscores a strong genetic contribution and reveals novel epigenetic alterations in the human epigenome

48. A genome-wide meta-analysis yields 46 new loci associating with biomarkers of iron homeostasis

49. Assessing the contribution of rare-to-common protein-coding variants to circulating metabolic biomarker levels via 412,394 UK Biobank exome sequences

50. Integrated Analyses of Growth Differentiation Factor-15 Concentration and Cardiometabolic Diseases in Humans

Catalog

Books, media, physical & digital resources